ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
6608	Centers for Disease Control and Prevention	Html	en	Preventing chronic disease in women of reproductive age: opportunities for health promotion and preventive services.	Improving the health of women of reproductive age extends beyond focusing on pregnancy and birth outcomes. Approaching women’s health from a life course perspective offers an opportunity to reduce overall and pregnancy-related illnesses and deaths and to eliminate disparities through enhanced health promotion and disease prevention.	preconception health awareness 0.418775 Health Resource Services 0.416545 public health interventions 0.401773 u.s. medical eligibility 0.503802 Child Health Bureau 0.406946 chronic heart disease 0.545078 chronic disease risk 0.459173 women’s health 0.455709 certain chronic diseases 0.399288 Disease Control 0.573611 chronic disease conditions 0.459235 National Center 0.450368 risk factors 0.512431 World Health Organization 0.402253 chronic medical conditions 0.440363 interconception health status 0.388488 Affordable Care Act 0.428067 health status 0.390648 Health Statistics 0.379084 chronic disease 0.92193 wellness health screening 0.405154 chronic disease prevention 0.696979 women 0.496631 sexually active women 0.370916 adverse pregnancy outcomes 0.363831	United States 0.362636 Child Health Epidemiology 0.409062 state health policies 0.404081 health promotion 0.550523 project targeted women 0.35938 reproductive-aged women 0.361072 Pregnancy Risk Assessment 0.447248 public health approach 0.394759 state health department 0.415169 public health 0.473586 chronic disease–related risk 0.433735 chronic diseases 0.463052 interconception health services 0.407041 reproductive age 0.792688 postpartum health visits 0.395105 health 0.703296 chronic disease programs 0.450704 chronic conditions 0.358994 health care visits 0.405041 medical eligibility criteria 0.500493 Public Health Service 0.388153 chronic disease prevalence 0.466741 Risk Assessment Monitoring 0.435115 various chronic disease 0.453192	CLICK HERE
6715	Centers for Disease Control and Prevention	Html	en	Bat Influenza (Flu)	Bat Influenza (Flu) - CDC	South America 0.340263 form bat flu 0.358587 CDC 0.27535 surface protein-coding gene 0.23206 Global Disease Detection 0.230817 Central 0.229413 high-throughput sequencing instruments 0.230934 new flu viruses 0.40172 CDC Rabies program 0.243425 Regional Center 0.230747 GDD Guatemala Regional 0.232832 single host cell 0.234813 pathogenic viruses 0.284401 new bat flu 0.388209 bat populations 0.251686 laboratory research 0.240233 different bat flu 0.355324 CDC’s Division 0.23013 human flu viruses 0.509683 CDC’s laboratories 0.228947 healthy bats 0.231905 human respiratory tract 0.232166 new animal species 0.235577 little yellow-shouldered bats 0.285597 bat flu viruses 0.848328	significant changes 0.239997 flu virus biology 0.312721 dangerous viruses 0.291165 continental United States 0.237564 CDC’s Pathogen 0.230309 bat flu virus 0.425097 bats 0.295197 flu researchers 0.303897 internal genes 0.25942 genetic information 0.23186 Preliminary laboratory research 0.234843 CDC scientists 0.264762 considerable genetic diversity 0.231735 monitor flu viruses 0.392639 flu viruses 0.958453 HA surface proteins 0.237191 Universidad del Valle 0.230245 Flu scientists 0.30037 Pathogen Discovery Program 0.297388 NA surface proteins 0.262456 surface proteins 0.281751 ancient bat flu 0.348958 Initial viral screening 0.229626 bat influenza viruses 0.339421	CLICK HERE
7589	Centers for Disease Control and Prevention	Html	en	Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	13-valent pneumococcal conjugate 0.562264 Pneumococcal vaccine-naУÐ?ve persons 0.549516 HIV-infected persons 0.545394 vaccine efficacy 0.684586 initial study dose 0.643175 polysaccharide vaccine 0.797614 implemented vaccine program 0.582662 advisory committee 0.698795 one-time revaccination dose 0.571822 cochlear implants 0.68499 pneumococcal conjugate vaccine 0.861952 7-valent pneumococcal conjugate 0.590916 previous PPSV23 dose 0.617488 persons 0.589881 current PPSV23 recommendations 0.570256 dose 0.678622 Conjugate pneumococcal vaccine 0.609656 PCV13 dose 0.614379 PCV13 vaccine efficacy 0.648678 high risk 0.546941 pneumococcal polysaccharide vaccine 0.737038 CSF leaks 0.64147 single dose 0.583541 pneumococcal vaccination opportunity 0.534862 United States 0.702259	adults 0.967119 immunocompromising conditions 0.79022 23-valent pneumococcal polysaccharide 0.650772 invasive pneumococcal disease 0.61783 HIV-infected adults 0.861418 Immunization Practices 0.66214 immunocompromised adults 0.634655 vaccine serotypes 0.590239 previous PPSV23 vaccination 0.561799 anatomic asplenia 0.576984 capsular polysaccharide vaccine 0.600014 general U.S. HIV-infected 0.566591 HIV-1-infected Ugandan adults 0.542206 vaccine group 0.569474 PPSV23 dose 0.622493 unpublished data 0.554776 adverse events 0.553304 polysaccharide pneumococcal vaccines 0.551719 acip recommendations 0.643709 ACIP PPSV23 recommendations 0.639817 new ACIP recommendations 0.618338 PPSV23 0.675988 et al 0.792518 IPD 0.613935	CLICK HERE
9581	Centers for Disease Control and Prevention	Html	en	CDC Newsroom Image Library Buildings and Facilities | CDC Media Relations	Free public health images, medical images, high-resolution, public domain images.	PHIL ID number 0.258483 James Gathany 0.38262 organization′s Roybal Campus 0.366596 content provider 0.284851 Tom Harkin Global 0.24594	Disease Control 0.381703 CDC′s Roybal campus 0.942536 Emergency Operations Center 0.671335 Photo Credit 0.38317 Arlen Specter Headquarters 0.809351	CLICK HERE
9990	Centers for Disease Control and Prevention	Html	en	Daniel Payne | Conversations with the Director | CDC Director | CDC	The CDC Director’s webpage offers information on Dr. Thomas Frieden, who became the agency’s 16th director in June 2009. The pages features information on Dr. Frieden’s Weekly Focus, the Latest from Dr. Frieden (his RSS feed), and links to his bio, statements, videos, press releases, media appearances, photos, presentations, and speeches.	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
10016	Centers for Disease Control and Prevention	Html	en	Guide to Writing for Social Media | Social Media | CDC	Basic information from CDC about breast cancer.	CDC 0.448034 social media messages 0.419143 family physicians 0.370493 social media communication 0.399877 Audience Insights—Communicating 0.382458 social media audiences 0.403942 social media efforts 0.398027 social media content 0.490533 different social media 0.397144 social media tools 0.448401 social media channels 0.487931 effective social media 0.402917 Facebook 0.403155 social media writers 0.400796 Social Media Guidelines 0.444297 CDC share health 0.374348 Social Media Toolkit 0.398926 social media information 0.410441 CDC health communication 0.387822 text messages 0.5001 plain language 0.458863 health literacy 0.401381 social marketing concepts 0.374632 social media communications 0.39506 United States 0.381845	commonly recognized abbreviations 0.37452 Twitter 0.393407 Web content 0.420416 cell phone 0.3882 short message service 0.384241 140 characters 0.375579 social marketing 0.432674 social media activities 0.401395 social media message 0.41907 Social Marketing Practice 0.370323 Electronic Media Branch 0.370049 Relevant social media 0.395672 Interesting social media 0.389111 social media 0.952927 social networking sites 0.397329 Facebook post 0.375911 cell phones 0.372524 health 0.424909 CDC’s Audience 0.398843 Social Media Content–Types 0.380529 social media strategy 0.419974 Web page 0.397893 best practices 0.379598 social media channel 0.399896	CLICK HERE
10948	Centers for Disease Control and Prevention	Html	en	Prostate Cancer Screening Tests	Two tests are commonly used to screen for prostate cancer: a digital rectal exam and a prostate specific antigen (PSA) test.	nurse inserts 0.33411 rule 0.221582 prostate infection 0.52106 PSA level 0.645157 Digital rectal exam 0.448317 men 0.221792 PSA levels 0.642207 PSA test results 0.62408 PSA 0.803107 finger 0.226242 best person 0.314889 abnormalities 0.231299 enlarged prostate 0.53696 substance 0.224368 prostate glands 0.535193 blood 0.268394 prostate problem 0.530339	Cancer screening 0.333161 factors 0.244295 lumps 0.23475 doctor 0.2439 symptoms 0.22486 prostate cancer 0.615552 prostate cancer— 0.565113 Certain medical procedures 0.41974 tests 0.223438 size 0.222707 Certain medications 0.32655 DRE 0.233645 biopsy 0.228873 prostate 0.951934 rectum 0.237536 prostate cancers 0.604513	CLICK HERE
13924	Centers for Disease Control and Prevention	Html	en	Notes from the Field: Carbapenem-resistantEnterobacteriaceae Producing OXA-48-like Carbapenemases - UnitedStates, 2010-2015	The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). Often called 'the Voice of CDC,' the MMWR series is the agency's primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominately consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.	U.S. reports 0.22594 rapid global dissemination 0.328095 carbapenemase-producing CRE 0.619213 additional published reports 0.329127 OXA-48 carbapenemase 0.236227 CDC Health Advisory 0.335635 U.S. clinical laboratories 0.301224 Zoonotic Infectious Diseases 0.305979 Maroya Walters 0.237775 different susceptibility profiles 0.307609 K. pneumoniae 0.37804 carbapenem antibiotics 0.232509 OXA-48-like carbapenemase genes 0.347322 patients 0.547463 OXA-48-like carbapenemases 0.777871 Brandi Limbago 0.241756 carbapenemase enzymes 0.236561 Kamile Rasheed 0.251654 Klebsiella pneumoniae carbapenemase 0.403571 Meghan Lyman 0.250921 CRE 0.806063 health care settings 0.308734 high transfer efficiency 0.302421 1Epidemic Intelligence Service 0.30877	Klebsiella ozaenae isolate 0.354316 health care–associated infections 0.342189 United States 0.913286 CDC CRE surveillance 0.596093 Meghan M. Lyman 0.316523 non-K. pneumoniae carbapenemases 0.351619 Healthcare Quality Promotion 0.308541 New Delhi metallo-β-lactamase 0.549854 plasmid-mediated resistance 0.244786 OXA-48-producing CRE 0.476667 public health concern 0.340617 frequently reported destination 0.321945 different clusters 0.225961 Alexander Kallen 0.242078 high mortality rates 0.336818 OXA-48-like genes 0.232859 OXA-48-like variants 0.247702 CRE resistance mechanisms 0.585753 enhanced environmental cleaning 0.329196 CRE screening 0.481109 Newly described resistance 0.344355 David Lonsway 0.239262 U.S. K. pneumoniae 0.370653 isolates 0.313706	CLICK HERE
16008	Centers for Disease Control and Prevention	Html	null	Safety of Influenza Vaccines	Safety of Influenza Vaccines - CDC			CLICK HERE
16506	Centers for Disease Control and Prevention	Html	en	Guideline Resources: Mobile App	null	Apple Store 0.408355 Morphine Milligram Equivalent 0.543535 chronic pain 0.542776 new Opioid Guideline 0.807861 renal insufficiency 0.416518 palm 0.31956 clinical practice 0.421488 approximations 0.326448 palliative care 0.408634 tools 0.31961 genetic factors 0.404624 different opioids 0.534435 iOS devices 0.417932 patient weight 0.401885 free download 0.408926 Opioid Guideline App 0.99731 Prescribing Opioids 0.58693 Google Play 0.406757 incomplete cross-tolerance 0.405731 fentanyl 0.329067 pharmacokinetics 0.328391 *MME Calculator Disclaimer 0.52137 CDC’s Guideline 0.572193	hand 0.319535 calculator* 0.317938 Android devices 0.415293 patients 0.328684 confidence 0.319565 opioid rotation 0.538887 clinical judgement 0.414046 resources 0.319585 opioid dosing 0.56739 methadone conversions 0.40736 active cancer treatment 0.493992 opioid use disorder 0.540045 application 0.333498 guidance 0.338952 interactive motivational interviewing 0.510216 effective communications skills 0.504336 CDC Opioid Guideline 0.778169 key recommendations 0.415024 entire guideline 0.532951 Equianalgesic dose ratios 0.500838 medication-assisted treatment 0.402412 providers 0.336382	CLICK HERE